Skip to main content
Premium Trial:

Request an Annual Quote

A Pharma Critic in Charge? Let the Lobbying Begin

Now that Tom Daschle has been recommended for the post of secretary of the US Department of Health and Human Services, advocacy groups are taking the opportunity to lobby him on his selection of a new FDA commissioner, according to this story in the Wall Street Journal. One new coalition formed expressly for this purpose has sent Daschle a letter saying that "relationships with the industry should be viewed as a 'positive qualification' for candidates, not as a black mark," the article says.

Over at Pharmalot, Ed Silverman blogs about the topic, noting that the push to name someone who has links to industry follows on speculation that frontrunners for the position include Steve Nissen and Joshua Sharfstein, both of whom have been highly critical of certain pharma companies.

 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.